BioMarin Pharmaceutical Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMRN Nasdaq 2834 https://www.biomarin.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical (NASDAQ:BMRN shareholders incur further losses as stock declines 4.9% this week, taking five-year losses to 14% - May 11th, 2022 11:32 am
BioMarin Hires Pharmaceutical Industry Leaders in Marketing and Accounting to Fill Strategic Roles Supporting Company's Growth Plans - May 5th, 2022 8:04 pm
BioMarin to Present Findings from Ongoing Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the World Federation of Hemophilia 2022 World Congress, May 8-11, 2022, Including Five Platform Presentations - May 5th, 2022 12:29 pm
BioMarin to Participate in the BofA Securities 2022 Healthcare Conference, Thursday, May 12 at 8:40amPT/11:40amET - May 4th, 2022 1:00 pm
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates - May 2nd, 2022 3:04 pm
ResMed (RMD) Q3 Earnings Miss Estimates, Margins Decline - May 2nd, 2022 12:34 pm
Alnylam (ALNY) Misses on Q1 Earnings, Lowers '22 Revenue View - Apr 29th, 2022 4:33 pm
BioMarin (BMRN) Q1 Earnings and Revenues Beat Estimates - Apr 28th, 2022 6:35 pm
Alkermes (ALKS) Q1 Earnings Beat Estimates, Revenues Rise Y/Y - Apr 28th, 2022 4:30 pm
BioMarin Pharmaceutical (BMRN) Q1 Earnings and Revenues Surpass Estimates - Apr 27th, 2022 9:25 pm
BioMarin Announces Record Revenues in First Quarter 2022 - Apr 27th, 2022 8:02 pm
Drug/Biotech Stocks' Apr 27 Q1 Earnings Roster: GSK, AMGN & More - Apr 26th, 2022 3:44 pm
BioMarin to Host First Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, April 27, at 4:30pm ET - Apr 13th, 2022 1:00 pm
Why Is BioMarin (BMRN) Up 4.6% Since Last Earnings Report? - Mar 25th, 2022 3:30 pm
BioMarin Announces Publication in New England Journal of Medicine of One-Year Results from Phase 3 Pivotal Trial with Valoctocogene Roxaparvovec Gene Therapy in Adults with Severe Hemophilia A - Mar 17th, 2022 12:31 pm
Sanofi's (SNY) Hemophilia A Candidate Meets Study Endpoints - Mar 10th, 2022 3:26 pm
Why BioMarin Pharmaceutical Tumbled on Thursday - Feb 24th, 2022 10:09 pm
BioMarin (BMRN) Q4 Earnings Top Estimates, Sales Fall Y/Y - Feb 24th, 2022 3:50 pm
BioMarin Pharmaceutical (BMRN) Q4 Earnings and Revenues Top Estimates - Feb 23rd, 2022 10:25 pm
BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates - Feb 23rd, 2022 9:03 pm